৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Quantity:
Products
Payment
Delivery
Respiratory tract infections
Ear, Nose, and Throat (ENT) infections
Urinary tract infections (UTIs)
Skin and soft tissue infections
Should be taken only under medical supervision.
Not suitable for patients with antibiotic allergies.
Possible side effects include gastrointestinal upset, allergic reactions, and skin rashes.
Nebivolol + Valsartan is a fixed-dose combination used in the management of hypertension. It combines a beta-blocker (Nebivolol) with an angiotensin II receptor blocker (Valsartan) to provide dual blood pressure control.
Nebivolol: Beta-1 selective adrenergic blocker with nitric oxide–mediated vasodilatory properties.
Valsartan: Angiotensin II receptor blocker (ARB).
Used to lower high blood pressure and reduce cardiovascular risk in patients with hypertension.
Nebivolol: Blocks beta-1 receptors, reducing heart rate and cardiac output; also promotes vasodilation via nitric oxide release.
Valsartan: Blocks angiotensin II receptors, preventing vasoconstriction and reducing aldosterone-mediated sodium retention.
Together: Provide synergistic blood pressure reduction and vascular protection.
Dual mechanism for better blood pressure control.
Reduces risk of stroke, heart attack, and heart failure progression.
Convenient fixed-dose combination improves compliance.
Nebivolol’s vasodilatory effect may improve tolerability compared to older beta-blockers.
Oral tablets (various strengths combining Nebivolol and Valsartan).
Dose individualized based on patient’s blood pressure and physician’s advice.
Effective control of hypertension.
Improves vascular function and reduces cardiac workload.
Enhances patient adherence with single-pill therapy.
May reduce cardiovascular morbidity and mortality.











